mRNA |
epigallocatechin-3-monogallate |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
2e-05 |
mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
2e-05 |
mRNA |
prima-1 |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
3e-05 |
mRNA |
NSC632839 |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
4e-05 |
mRNA |
BRD-K52037352 |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
4e-05 |
mRNA |
SID 26681509 |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
5e-05 |
mRNA |
PL-DI |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
5e-05 |
mRNA |
PF-184 |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
7e-05 |
mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
7e-05 |
mRNA |
Cerulenin |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
7e-05 |